Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene

Neuroscience Letters

Volumn 368, Issue 1, 2004, Pages 33-36

  Craig, David ^a   Hart, Dominic J ^a   Carson, Robyn ^a   McIlroy, Stephen P ^a   Passmore, A Peter ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Alzheimer's disease; Behaviour; BPSD; Dementia; Dopamine; DRD3; Genetic; Polymorphism; Psychosis

Indexed keywords

DOPAMINE 3 RECEPTOR;

AFFECTIVE PSYCHOSIS; AGED; ALLELE; ALZHEIMER DISEASE; ANAMNESIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DELUSION; DISEASE DURATION; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HALLUCINATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PRIORITY JOURNAL; RECEPTOR GENE; SEX RATIO;

AGED; ALLELES; ALZHEIMER DISEASE; COHORT STUDIES; DELUSIONS; DNA; FEMALE; GENOTYPE; HALLUCINATIONS; HUMANS; LOGISTIC MODELS; MALE; MUTATION; PSYCHOTIC DISORDERS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 4444287079     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.06.052     Document Type: Article

References (24)

1. S.A. Bacanu, B. Devlin, K.V. Chowdari, S.T. DeKosky, V.L. Nimgaonkar, and R.A. Sweet Linkage analysis of Alzheimer disease with psychosis Neurology 59 2002 118 120
2. Census Office for Northern Ireland. Census Summary Report, Table 7, 1991.
3. D.P. Devanand, D.M. Jacobs, M.X. Tang, C. Del Castillo-Castaneda, M. Sano, K. Marder, K. Bell, F.W. Bylsma, J. Brandt, M. Albert, and Y. Stern The course of psychopathologic features in mild to moderate Alzheimer disease Arch. Gen. Psychiatry 54 1997 257 263
4. C. Dubertret, P. Gorwood, J. Ades, J. Feingold, J.C. Schwartz, and P. Sokoloff Meta-analysis of DRD3 gene and schizophrenia: ethnic heterogeneity and significant association in Caucasians Am. J. Med. Genet. 81 1998 318 322
5. A. Eustace, R. Coen, C. Walsh, C.J. Cunningham, J.B. Walsh, D. Coakley, and B.A. Lawlor A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease Int. J. Geriatr. Psychiatry 17 2002 968 973
6. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J. Psychiatr. Res. 12 1975 189 198
7. V.E. Golimbet, M.V. Alfimova, K.K. Manandyan, N.G. Mitushina, L.I. Abramova, V.G. Kaleda, I.V. Oleichik, Y. Yurov, and V.I. Trubnikov 5HTR2A gene polymorphism and personality traits in patients with major psychoses Eur. Psychiatry 17 2002 24 28
8. M. Haupt, A. Kurz, and M. Janner A 2-year follow-up of behavioural and psychological symptoms in Alzheimer's disease Dement. Geriatr. Cognit. Disord. 11 2000 147 152
9. C. Holmes, M.J. Arranz, J.F. Powell, D.A. Collier, and S. Lovestone 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease Hum. Mol. Genet. 7 1998 1507 1509
10. C. Holmes, H. Smith, R. Ganderton, M. Arranz, D. Collier, J. Powell, and S. Lovestone Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation J. Neurol. Neurosurg. Psychiatry 71 2001 777 7779
11. T. Hope, J. Keene, C.G. Fairburn, R. Jacoby, and R. McShane Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease Br. J. Psychiatry 174 1999 39 44
12. E.G. Jonsson, L. Flyckt, E. Burgert, M.A. Crocq, K. Forslund, M. Mattila-Evenden, G. Rylander, M. Asberg, V.L. Nimgaonkar, G. Edman, L. Bjerkenstedt, F.A. Wiesel, and G.C. Sedvall Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis Psychiatr. Genet. 13 2003 1 12
13. D.I. Kaufer, J.L. Cummings, D. Christine, T. Bray, S. Castellon, D. Masterman, A. MacMillan, P. Ketchel, and S.T. DeKosky Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale J. Am. Geriatr. Soc. 46 1988 210 215
14. O.L. Lopez, J.T. Becker, R.A. Sweet, W. Klunk, D.I. Kaufer, J. Saxton, M. Habeych, and S.T. Dekosky Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease J. Neuropsychiatry Clin. Neurosci. 15 2003 346 353
15. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944
16. S.P. McIlroy, V.L. Crawford, K.B. Dynan, B.M. McGleenon, M.D. Vahidassr, J.T. Lawson, and A.P. Passmore Butyryllcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland J. Med. Genet. 37 2000 182 185
17. S.A. Miller, D.D. Dykes, and H.F. Polesky A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res. 16 1988 1215
18. B. Nacmias, A. Tedde, P. Forleo, S. Piacentini, B.M. Guarnieri, A. Bartoli, L. Ortenzi, C. Petruzzi, A. Serio, G. Marcon, and S. Sorbi Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease Biol. Psychiatry 50 2001 472 475
19. V.L. Nimgaonkar, A.R. Sanders, R. Ganguli, X.R. Zhang, J. Brar, W. Hogge, W.E. Fann, P.I. Patel, and A. Chakravarti Association study of schizophrenia and the dopamine D3 receptor gene locus in two independent samples Am. J. Med. Genet. 67 1996 505 514
20. Scottish/Northern Irish BRCAI/BRCA2 Consortium BRCA1 and BRCA2 mutations in Scotland and Northern Ireland Br. J. Cancer 88 2003 1256 1262
21. Y. Stern, M. Albert, J. Brandt, D.M. Jacobs, M.-X. Tang, K. Marder, K. Bell, M. Sano, D. Devanand, F. Bylsma, and G. Lafleche Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study Age Ageing 26 1997 367 374
22. R.A. Sweet, V.L. Nimgaonkar, M.I. Kamboh, O.L. Lopez, F. Zhang, and S.T. DeKosky Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease Arch. Neurol. 55 1998 1335 1340
23. R.A. Sweet, V.L. Nimgaonkar, B. Devlin, and D.V. Jeste Psychotic symptoms in Alzheimer's disease: evidence for a distinct phenotype Mol. Psychiatry 8 2003 383 392
24. J. Williams, P. McGuffin, M. Nothen, and M.J. Owen Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. European Multicentre Association Study of Schizophrenia. EMASS Collaborative Group Lancet 349 1997 1221